Dynamics of cancer cell subpopulations in primary and metastatic colorectal tumors

Clinical and Experimental Metastasis

Volumn 28, Issue 5, 2011, Pages 427-435

  Goranova, Teodora Evgenieva ^a,b   Ohue, Masayuki ^a   Shimoharu, Yutaro ^a   Kato, Kikuya ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b Molecular Medicine Center   (Bulgaria)

Author keywords

Colorectal cancer; Intratumor heterogeneity; Molecular target drug; Somatic mutation

Indexed keywords

APC PROTEIN; K RAS PROTEIN; PROTEIN P53;

ALLELIC IMBALANCE; ARTICLE; CANCER CELL; CANCER STAGING; CANCER TISSUE; CELL SUBPOPULATION; COLORECTAL CANCER; DRUG EFFICACY; GENE MUTATION; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; HUMAN TISSUE; LIVER METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; MUTATIONAL ANALYSIS; PRIMARY TUMOR;

ADENOMATOUS POLYPOSIS COLI PROTEIN; COLORECTAL NEOPLASMS; GENOTYPE; HUMANS; MUTATION; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79955521656     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-011-9381-0     Document Type: Article

References (23)

1. JE Visvader GJ Lindeman 2008 Cancer stem cells in solid tumours: accumulating evidence and unresolved questions Nat Rev Cancer 8 10 755 768 18784658 10.1038/nrc2499 1:CAS:528:DC%2BD1cXhtFCrtb3K
2. B Baisse H Bouzourene EP Saraga, et al. 2001 Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma Int J Cancer 93 3 346 352 11433398 10.1002/ijc.1343 1:CAS:528:DC%2BD3MXlt12gsLk%3D (Pubitemid 32592052)
3. R Barnetson J Jass R Tse, et al. 2000 Mutations associated with microsatellite unstable colorectal carcinomas exhibit widespread intratumoral heterogeneity Genes Chromosomes Cancer 29 2 130 136 10959092 10.1002/1098-2264(200010)29:2<130::AID-GCC1023>3.0.CO;2-Z 1:CAS:528:DC%2BD3cXntVWiurs%3D
4. W Giaretti A Rapallo A Sciutto, et al. 2000 Intratumor heterogeneity of k-ras and p53 mutations among human colorectal adenomas containing early cancer Anal Cell Pathol 21 2 49 57 11310641 1:CAS:528:DC%2BD3MXjs1Smtr0%3D (Pubitemid 32238922)
5. I Gonzalez-Garcia RV Sole J Costa 2002 Metapopulation dynamics and spatial heterogeneity in cancer Proc Natl Acad Sci USA 99 20 13085 13089 12351679 10.1073/pnas.202139299 1:CAS:528:DC%2BD38XnvFGhur4%3D
6. N Konishi Y Hiasa H Matsuda, et al. 1995 Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma Am J Pathol 147 4 1112 1122 7573356 1:CAS:528:DyaK2MXpslWgtbk%3D
7. L Losi B Baisse H Bouzourene, et al. 2005 Evolution of intratumoral genetic heterogeneity during colorectal cancer progression Carcinogenesis 26 5 916 922 15731168 10.1093/carcin/bgi044 1:CAS:528:DC%2BD2MXjsFOms7o%3D (Pubitemid 41214320)
8. H Lyng M Beigi DH Svendsrud, et al. 2004 Intratumor chromosomal heterogeneity in advanced carcinomas of the uterine cervix Int J Cancer 111 3 358 366 15221962 10.1002/ijc.20258 1:CAS:528:DC%2BD2cXmtlKmu7s%3D (Pubitemid 38998815)
9. WS Samowitz ML Slattery 1999 Regional reproducibility of microsatellite instability in sporadic colorectal cancer Genes Chromosomes Cancer 26 2 106 114 10469448 10.1002/(SICI)1098-2264(199910)26:2<106::AID-GCC2>3.0.CO;2-F 1:CAS:528:DyaK1MXmt1WhsLg%3D (Pubitemid 29416435)
10. Y Takeshima VJ Amatya Y Daimaru, et al. 2001 Heterogeneous genetic alterations in ovarian mucinous tumors: application and usefulness of laser capture microdissection Hum Pathol 32 11 1203 1208 11727259 10.1053/hupa.2001. 28956 1:CAS:528:DC%2BD38XhslSqtw%3D%3D (Pubitemid 33104431)
11. K Taniguchi J Okami K Kodama, et al. 2008 Intratumor heterogeneity of epidermal growth factor receptor mutations in lung cancer and its correlation to the response to gefitinib Cancer Sci 99 5 929 935 18325048 10.1111/j.1349-7006. 2008.00782.x 1:CAS:528:DC%2BD1cXlslCrtr4%3D (Pubitemid 351997594)
12. A Marusyk K Polyak 2010 Tumor heterogeneity: causes and consequences Biochim Biophys Acta 1805 1 105 117 19931353 1:CAS:528:DC%2BC3cXktVGltA%3D%3D
13. ER Fearon B Vogelstein 1990 A genetic model for colorectal tumorigenesis Cell 61 5 759 767 2188735 10.1016/0092-8674(90)90186-I 1:CAS:528: DyaK3cXktlyhtrg%3D (Pubitemid 20185636)
14. TE Goranova M Ohue K Kato 2009 Putative precursor cancer cells in human colorectal cancer tissue Int J Clin Exp Pathol 2 2 154 162 19079650 1:CAS:528:DC%2BD1cXht1alsr7L
15. PJ Campbell S Yachida LJ Mudie, et al. 2010 The patterns and dynamics of genomic instability in metastatic pancreatic cancer Nature 467 7319 1109 1113 20981101 10.1038/nature09460 1:CAS:528:DC%2BC3cXhtlCjt7%2FP
16. W De Roock H Piessevaux J De Schutter, et al. 2008 KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab Ann Oncol 19 3 508 515 17998284 10.1093/annonc/mdm496 (Pubitemid 351325672)
17. F Di Fiore F Blanchard F Charbonnier, et al. 2007 Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy Br J Cancer 96 8 1166 1169 17375050 10.1038/sj.bjc.6603685 1:CAS:528:DC%2BD2sXkt1Gqsbs%3D (Pubitemid 46625066)
18. JR Hecht A Patnaik J Berlin, et al. 2007 Panitumumab monotherapy in patients with previously treated metastatic colorectal cancer Cancer 110 5 980 988 17671985 10.1002/cncr.22915 1:CAS:528:DC%2BD2sXhtVChs7fN (Pubitemid 47312862)
19. S Khambata-Ford CR Garrett NJ Meropol, et al. 2007 Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab J Clin Oncol 25 22 3230 3237 17664471 10.1200/JCO.2006.10.5437 1:CAS:528:DC%2BD2sXhtVWqs7rF (Pubitemid 47325606)
20. A Lievre JB Bachet V Boige, et al. 2008 KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab J Clin Oncol 26 3 374 379 18202412 10.1200/JCO.2007.12.5906 1:CAS:528:DC%2BD1cXitVGntLc%3D (Pubitemid 351171687)
21. A Lievre JB Bachet D Le Corre, et al. 2006 KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer Cancer Res 66 8 3992 3995 16618717 10.1158/0008-5472.CAN-06-0191 1:CAS:528:DC%2BD28XjsFSlsb0%3D
22. A Italiano I Hostein I Soubeyran, et al. 2010 KRAS and BRAF mutational status in primary colorectal tumors and related metastatic sites: biological and clinical implications Ann Surg Oncol 17 5 1429 1434 20049644 10.1245/s10434-009-0864-z
23. SE Baldus KL Schaefer R Engers, et al. 2010 Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases Clin Cancer Res 16 3 790 799 20103678 10.1158/1078-0432.CCR-09-2446 1:CAS:528:DC%2BC3cXhs1aqsr4%3D